Objectives: This study aimed to examine the outcomes of endovascular recanalization for native superficial femoral artery (SFA) chronic total occlusion (CTO) in patients with critical limb ischemia (CLI) after femoropopliteal bypass failure with limited surgical revascularization options.
| INTRODUCTION
Lower extremity arterial bypass occlusion remains a challenging problem. Early graft occlusion rate (<30 days) has been reported to be 5-10%, [1] [2] [3] and late graft occlusion (>30 days) 20-50%. [4] [5] [6] Moreover, the overall limb salvage rate in patients with failed bypass graft is only about 50% at 2 years. 1, 5, 6 Thrombectomy or thrombolysis followed by graft revision was an option for intervention after bypass graft failure. However, the longterm patency and limb salvage seem to be unfavorable, 7, 8 Redo bypass has also been commonly performed for threatened limbs, with an inferior outcome compared with primary bypass [9] [10] [11] and carries a high complication rate. 12 In addition, surgical revascularization is not always suitable for the patients with advanced age, lack of conduit, unacceptable surgical risk, non-ambulatory status, presence of serious comorbidities, or adverse anatomical factors (pseudoaneurysm at the anastomosis).
In recent years, with the advancement of endovascular technology, improvement of stent graft and balloon, and accumulated experience of endovascular procedures, endovascular angioplasty has been widely utilized to treat chronic total occlusions of superficial femoral artery (SFA) with a favorable technical success rate and clinical prognosis. 13 This has led to the notion of performing recanalization of native SFA chronic total occlusions (CTOs) after failed bypass grafts in patients with limb-threatening ischemia who are poor candidates for surgical reconstruction due to high risk of perioperative complication and mortality. The feasibility of this approach has been demonstrated in other case-series studies for lesions at various levels. [14] [15] [16] In the present study, we present our experience with endovascular recanalization of native severely diseased occluded SFA, namely TASC C and D lesions, in patients with CLI after femoropopliteal bypass graft failure. We evaluated the outcomes of this kind of treatment modality and the risk factors of primary patency loss.
| METHODS

| Study group
This retrospective study was approved by the institutional review board of our hospital, and written informed consent was obtained from each patient. In a review of a prospectively maintained database in our center from June 2010 and December 2016, 45 limbs in 45
consecutive CLI patients were identified who had undergone endovascular recanalization of native SFA CTO following the occluded femoropopliteal bypass. All patients meet the inclusion and exclusion criteria. Inclusion criteria included: (i) presence of the previous femoropopliteal bypass graft occlusion; (ii) ischemia duration >14 days; (iii) failed conservative treatment before operation (ie, cigarette cessation, exercise, and medication); (iv) unfitness for redo bypass: lack of an adequate autogenous conduit for distal bypass, severe comorbidity (eg, congestive heart failure, symptomatic coronary artery disease, myocardial infarction, or stroke within the previous 6 weeks), severe lesions of infragenicular vessels (eg, pseudoaneurysm at the anastomosis and lack of infragenicular runoff), advanced age (≥80 years), and repeated bypass occlusions. Exclusion criteria included: (i) previous endovascular procedures involving the target native vessels;
(ii) anastomosis end to end during previous procedure; (iii) contraindication to antiplatelet drugs or heparin; (iv) severe renal insufficiency [glomerular filtration rate (GFR) <30 mL/min]; and (v) contrast medium allergic history. Duplex ultrasonography or computed tomography angiography was performed in all patients before operation to evaluate the site, length, proximal occlusion level, and distal runoff arteries.
| Treatment
All patients have been evaluated before procedure by a multidisciplin- 
| Follow-up
During follow-up, clinical examination, and duplex ultrasonography were performed at 1, 3, and 6 months after discharge, and every 6 months thereafter. Patency was determined by duplex ultrasonography and significant restenosis was defined as >2.5 of peak systolic velocity ratio. Contrast-enhanced computed tomography was per- 
| Statistical analysis
Individual data were summarized using frequencies or percentages for categorical factors and the Mean ± SD (range) for continuous variables.
Statistical analysis was performed using SPSS software (SPSS Inc, Chicago IL). Time-to-event data were analyzed by Kaplan-Meier survival methods. Risk factors associated with primary patency loss were explored through univariate and multivariate analyses using Cox proportional hazards regression models. A P-value of <0.05 was considered significant. Table 2 .
| RESULTS
No vessel rupture, perforation, distal embolization, or thrombosis occurred during the procedures. Early in-stent thrombosis (<30 days) occurred in 10 cases after procedure, which required reintervention, ultimately leading to 2 early below-knee amputation due to unsuccessful thrombolysis. One of the patient died of myocardial infarction after amputation.
In the 43 patients with technically successful treatment, the mean follow-up was 42.7 months (range, 1-62 months). A total of 41 patents (91.1%) were successfully followed up, while two patients were lost to follow up. The ABI showed a significant increase from 0.3 ± 0.1 to 0.7 ± 0.1 pre-to post-procedure (P <0.01 Limb salvage rate was 95% (±0.03 SE) ( Figure 3 ) and amputation-free survival rate was 88% (±0.05 SE) at both 12 and 36 months (Figure 4) . rates of 95% at both 12 and 36 months, which was more encouraging compared to redo surgery. This may be due to collateral preservation and enhancement during native arterial recanalization and subintimal angioplasty, while in a surgical operation they are often sacrificed.
Tissue integrity can be maintained through improved collateral circulation blood supply, even in the case of arterial reocclusion.
Further, outflow can be improved by correcting distal lesions at the same stage, which may be surgically inaccessible crural and pedal arteries lesions. More importantly, a straight-line flow to the foot may be established, though temporarily restored (1-to 6-month), which may be sufficient to relieve CLI. 14 The major disadvantage was high incidence of target lesion failure and high reintervention rates. In the present study, about half of the patients suffered from re-occlusion of the native arteries at 1 year follow up, and repeated intervention was required in 46.5% of patients. Most secondary intervention procedures were performed for acute thrombosis, which was mainly due to rapid recoil of fibrotic scar tissue and proliferation of anastomosis.
Nevertheless, this reintervention rate appears to be acceptable, considering the decent secondary patency rates (1-year, 78%; 3-year, 61%) and limb salvage rates in this selective patient cohort.
A few similar small case series on native CTO recanalization in graft failure have been previously reported. The results of these studies were similar to ours. The technical success rates were ranging from 89% to 100% and limb salvage rates were 81-94% and 65-96% at 1-and 2-years of follow-up. [14] [15] [16] [29] [30] [31] One-year primary and secondary patency rates in those studies ranged from 16% to 60% and from 44% to 96%, respectively. [14] [15] [16] 30, 31 And the rates of repeated intervention were between 38% and 50%. [30] [31] based on multivariate analysis. 33 Our study found similar result [HR 5.8; 95% CI 1.0-32.4, P = 0.047], despite of the width of the CI indicating the potential imprecision of the point estimate. Actually, the question of whether diabetes acts as an independent risk factor or a surrogate for other key variables remains controversial. As another study showed, the reduced primary patency of diabetics is most likely due to their advanced stage at presentation. 34 In terms of anastomosis occlusion, another risk factor, our finding (HR 2.877; 95% CI 1.1-6.7, P = 0.029) was similar to that of Yin et al study (HR 2.84; 95% CI 1.00-8.03, P = 0.049). 30 The effect of this factor was only found to be significant in univariate analysis. As is demonstrated in many studies, anastomotic lesions may negatively influence the results of revision of failed vein bypass graft. 35 This effect can also be observed in endovascular recanalization of native arteries, although the target lesions were different. A postulate was that the metabolic activity of these lesions next to anastomosis occlusion may predispose them to more unfavorable response after intervention. However, supportive data was lacking. The last risk factor was location of previous bypass distal anastomosis. The bypass target to below-knee popliteal artery may be associated with more extensive disease and higher TASC classification, which have been well-corroborated to be indication for restenosis after percutaneous intervention. 36 Although the effect was not significant in multivariate analysis, the present observations indicate that greater consideration should be given when endovascularly treat native lesions with a failed below-knee bypass. There are several limitations in including its retrospective nature, patient heterogeneity, small sample size from a single institution, lack of a control group, and limited follow-up. Nevertheless, the study does 
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